Article · Journal · 2025

Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique

Clinical Infectious Diseases

Citations: 2from other works
Field-weighted impact: 1.281.00 is the world average for its field and year
Among its field: 79th percentileby citations, against works of its field and year
Authors: 40from 12 institutions

Authors

40 authors across 12 institutions in 10 countries